A Study Protocol for a Comprehensive Evaluation of Two Artificial Intelligence‐Based Tools in Title and Abstract Screening for the Development of Evidence‐Based Cancer Guidelines
This will be the first study to investigate and compare the performance of DistillerSR and EPPI-Reviewer in Stage I screening of SRs in CPGs across different cancer types. These findings will inform the reliable use of AI tools in future cancer-related CPGs. The results from this retrospective study will need to be confirmed by prospective studies.
Authors
- Jonathan Sussman (ORCID: https://orcid.org/0000-0002-7702-8816)
- Ashley Low
- Xiaomei Yao (ORCID: https://orcid.org/0000-0002-1210-3758)
- Ashirbani Saha (ORCID: https://orcid.org/0000-0002-7650-1720)
- S Saravanan
Institutions
- Impact (CA)
- McMaster University (CA)
Publication Details
- Journal
- Cancer Innovation
- Published
- 2025-06-29
- DOI
- https://doi.org/10.1002/cai2.70021
- Citations
- 6
- Primary Topic
- Clinical practice guidelines implementation
- Type
- article
- Field-Weighted Citation Impact
- 11.27
Funders
- Hamilton Health Sciences
- Hamilton Health Sciences Foundation